Chromosomal translocation engineering to recapitulate primary events of human cancer
Abstract:
Mouse models of human cancers are important for understanding determinants of overt disease and for "preclinical" development of rational therapeutic strategies; for instance, based on macrodrugs. Chromosomal translocations underlie many human leukemias, sarcomas, and epithelial tumors. We have developed three technologies based on homologous recombination in mouse ES cells to mimic human chromosome translocations. The first, called the knockin method, allows creation of fusion genes like those typical of translocations of human leukemias and sarcomas. Two new conditional chromosomal translocation mimics have been developed. The first is a method for generating reciprocal chromosomal translocations de novo using Cre-loxP recombination (translocator mice). In some cases, there is incompatible gene orientation and the translocator model cannot be applied. We have developed a different model (invertor mice) for these situations. This method consists of introducing an inverted cDNA cassette into the intron of a target gene and bringing the cassette into the correct transcriptional orientation by Cre-loxP recombination. We describe experiments using the translocator model to generate MLL-mediated neoplasias and the invertor method to generate EWS-ERG-mediated cancer. These methods mimic the situation found in human chromosome translocations and provide the framework for design and study of human chromosomal translocations in mice.
Insights
Researchers developed novel mouse models to mimic human chromosomal translocations, crucial for understanding cancer development and testing new therapies. These advanced models enable precise study of gene fusions and their role in various cancers.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Chromosomal translocations are key drivers in numerous human cancers, including leukemias, sarcomas, and epithelial tumors.
- Accurate mouse models are essential for dissecting cancer etiology and advancing preclinical therapeutic development.
Purpose of the Study:
- To develop novel mouse models that accurately mimic human chromosomal translocations.
- To provide a framework for studying the role of specific translocations in cancer development and for evaluating therapeutic strategies.
Main Methods:
- Utilized homologous recombination in mouse embryonic stem (ES) cells to engineer three distinct translocation models.
- Developed a "knockin" method for creating fusion genes characteristic of human leukemias and sarcomas.
- Created conditional translocation mimics: "translocator mice" using Cre-loxP recombination for reciprocal translocations and "invertor mice" for incompatible gene orientations.
Main Results:
- Successfully generated MLL-mediated neoplasias using the translocator model.
- Demonstrated the utility of the invertor method in generating EWS-ERG-mediated cancer.
- Validated the ability of these models to replicate human chromosomal translocation scenarios.
Conclusions:
- The developed knockin, translocator, and invertor mouse models effectively mimic human chromosomal translocations.
- These models offer a powerful platform for investigating the mechanisms of translocation-driven cancers.
- They facilitate the design and preclinical evaluation of targeted therapies for human cancers caused by chromosomal abnormalities.
More Related Videos
Related Concept Videos
Homologous Recombination
Gene Conversion
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...


